Cell-based 3D bionic screening by mimicking the drug-receptor interaction environment in vivo

Area of Science:

• Biotechnology
• Drug Discovery
• Pharmacology

Background:

• Small-molecule drugs interact with cellular proteins, but efficacy is often unpredictable without biological context.
• Current drug discovery methods may lack in vivo relevance, leading to late-stage development failures.
• Bionic screening offers an in vivo platform to identify active small molecules, enhancing clinical success likelihood.

Purpose of the Study:

• To design and validate an innovative cell-based bionic screening system for small-molecule drug discovery.
• To simulate in vivo conditions using 3D microcarrier cultures for more accurate drug-receptor interaction assessment.
• To combine the system with HPLC/MS for unbiased identification of lead compounds in complex biological systems.

Main Methods:

• Development of a cell-based bionic screening system utilizing 3D microcarrier cultures.
• Integration of High-Performance Liquid Chromatography/Mass Spectrometry (HPLC/MS) for compound identification.
• Assessment of drug-receptor interactions in a high-density, tissue-mimicking cellular environment.

Main Results:

• The 3D microcarrier system effectively mimics in vivo tissue morphology and drug-receptor interactions.
• The platform provides high-density cell coverage for affinity assessments without significant cell damage.
• The method is scalable, adaptable to various cell lines, and facilitates high-throughput screening.

Conclusions:

• The developed bionic screening system offers a physiologically relevant platform for small-molecule drug discovery.
• This approach improves the identification of effective lead compounds, potentially addressing the shortage of clinically available drugs.
• The system provides a valuable tool for advancing drug development in more relevant biological contexts.